Clinical trial
A three part, staggered cohort, open-label and double blind, randomized, placebo controlled study to investigate the efficacy, safety, tolerability and pharmacokinetics of eltrombopag, a thrombopoietin receptor agonist, in previously treated pediatric pat
To assess the efficacy of eltrombopag, relative to placebo, in achieving a platelet count ?50Gi/L at any time during a 6 week treatment period when administered to previously treated pediatric subjects with chronic ITP.
| Category | Value |
|---|---|
| Study start date | 2009-07-06 |